Shares of Brenntag AG (OTCMKTS:BNTGY – Get Free Report) have been given a consensus recommendation of “Reduce” by the nine research firms that are presently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation and eight have assigned a hold recommendation to the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $12.80.
Several equities analysts recently weighed in on the company. Morgan Stanley restated an “underweight” rating on shares of Brenntag in a research note on Friday, August 14th. Deutsche Bank Aktiengesellschaft downgraded Brenntag from a “buy” rating to a “hold” rating in a research report on Tuesday, June 16th. Jefferies Financial Group upgraded Brenntag from a “moderate sell” rating to a “hold” rating in a research report on Wednesday, May 20th. Finally, DZ Bank raised Brenntag from a “strong sell” rating to a “hold” rating in a research note on Monday, July 27th.
Get Our Latest Research Report on BNTGY
Brenntag Stock Performance
Brenntag (OTCMKTS:BNTGY – Get Free Report) last issued its quarterly earnings data on Wednesday, August 12th. The company reported $0.29 earnings per share for the quarter, topping analysts’ consensus estimates of $0.25 by $0.04. Brenntag had a net margin of 2.41% and a return on equity of 8.34%. The business had revenue of $4.96 billion during the quarter, compared to the consensus estimate of $4.66 billion. On average, equities analysts expect that Brenntag will post 0.85 EPS for the current year.
About Brenntag
Brenntag SE, trading on OTCMKTS as BNTGY, is a global market leader in the distribution of chemicals and ingredients. With headquarters in Essen, Germany, the company serves a wide range of industries including coatings and construction, cleaning and water treatment, food and nutrition, pharmaceuticals and personal care, as well as oil and gas. Brenntag operates through two core segments—Essentials and Specialties—offering both standard commodity chemicals and tailored specialty solutions to customers around the world.
Its product portfolio encompasses inorganic and organic chemicals, polymers, petrochemicals and specialty ingredients.
See Also
- Five stocks we like better than Brenntag
- Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected
- Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock
- Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement
- Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.
